跳至主要内容
临床试验/NCT01582828
NCT01582828撤回不适用

Serial Hybrid Atrial Fibrillation Ablation

Medisch Spectrum Twente2 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
162
试验地点
2
主要终点
Atrial fibrillation Freedom

研究概览

简要总结

Treatment of (long-standing) persistent atrial fibrillation (AF) remains cumbersome and the surgical (epicardial) approach seems to be the most effective. Still, however a significant amount of failures exist which is mostly due to incompleteness of the surgical ablation lines. Checking, and if necessary additional ablation, of these lines afterwards endocardially by the cardiologist (the so-called serial hybrid approach) could overcome this problem.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients are screened and accepted for pulmonary vein isolation according to the current guidelines
  • long standing persistent or persistent AF as defined in the guidelines
  • left atrial size needs to be more than >46 mm on long axis or >35 cc/m2
  • CHADSVASC score should be more than 0 as an indicator of a substantial substrate for atrial fibrillation.

排除标准

  • Significant coronary artery disease has to be excluded as a trigger for AF by means of cardiac CT, if necessary a coronary angiogram will be performed.
  • Previous PVI ablation (epicardial or endocardial) or cardiac surgery.
  • Significant valvular disease present on echo.
  • Concomitant cardiac surgery needed.

结局指标

主要结局

Atrial fibrillation Freedom

时间窗: 12 months

left sided atrial flutter and left atrial tachycardia

次要结局

  • re-isolation(8-10 weeks)
  • Percentage of cross-over(1 year)
  • Complications(1 year)
  • Atrial fibrillation Burden(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

B. Oude Velthuis

Research fellow electrophysiology

Medisch Spectrum Twente

研究点 (2)

Loading locations...

相似试验